What is NIVF (NIVF) stock price today?

NIVF (NIVF) is currently trading at $1.05, down 4.55% today.

What is NIVF P/E ratio?

NIVF's P/E ratio is 0.04. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is NIVF return on equity (ROE)?

NIVF's return on equity (ROE) is 37.04%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is NIVF's market cap?

NIVF has a market capitalization of $198988.

NASDAQ · Medical - Healthcare Plans

NIVF (NIVF) Stock

$1.05 -4.55% NASDAQ: NIVF Healthcare

Valuation

Metric	Value
Price	$1.05
Market Cap	$198988
P/E Ratio	0.04
P/B Ratio	0.02
P/S Ratio	0.25
EPS (TTM)	$16.80
52-Week High	$372.00
52-Week Low	$0.43
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	37.04%
ROA	30.30%
ROCE	-42.31%
Gross Margin	-200.00%
Operating Margin	-220.00%
Net Margin	3.38%
Debt/Equity	0.18
Current Ratio	3.50

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$4.0M	$6.0M	$5.0M	$5.0M	$5.0M
Operating Profit	$0	$-1.0M	$0	$-1.0M	$-11.0M
Net Profit	$0	$0	$0	$-1.0M	$10.0M
EPS	$0.00	$62.52	$12.44	$-22.31	$16.80
Op Margin	4.8%	-8.5%	0.8%	-21.4%	-226.9%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$3.0M	$4.0M	$4.0M	$33.0M
Total Liabilities	$2.0M	$3.0M	$1.0M	$5.0M	$7.0M
Cash	$0	$0	$0	$0	$1.0M
Borrowings	$1.0M	$0	$0	$3.0M	$5.0M

Latest News

NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million GlobeNewswire · Jul 6, 2026 NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization GlobeNewswire · Jun 22, 2026 NewGenIvf to Invest Additional $4 Million in K25.ai, Increasing Stake to 10% MT Newswires · Jun 18, 2026 NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested GlobeNewswire · Jun 18, 2026 NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure GlobeNewswire · Jun 16, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$1.0M	$-1.0M	$-2.0M	$-8.0M	$-11.0M
Investing Cash Flow	$0	$-70.0M	$0	$0	$-13.0M
Financing Cash Flow	$-2.0M	$-2.0M	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$1.0M	$-1.0M	$-2.0M	$-8.0M	$-17.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-938.85%
Quick Ratio	2.98
Interest Coverage	-11.00
Return 1Y	-99.74%
Return 3Y	-100.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.51%

Institutions Float Held0.51%

Institutional Holder	Shares	Report Date
Tower Research Capital LLC (TRC)	500	2026-03-31
UBS Group AG	67	2026-03-31
SBI Securities Co., Ltd.	2	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CCMConcord Medical Services Holdings Limited	$4.32	+7.20%	-0.03	$629052	0.00%
CDT	$3.14	+9.60%	0.00	$1.53M	0.00%
COCH	$0.67	+1.71%	-0.74	$14.02M	0.00%
HEPAHepion Pharmaceuticals, Inc.	$0.05	+17.78%	-0.21	$617116	0.00%
IVF	$0.96	-4.09%	-0.01	$1.71M	0.00%

About NIVF

NIVF is led by CEO Wing Fung Siu, employs 76 people, headquartered in TH, publicly traded since 2022.

NIVF stock trades at $1.05 with a market capitalization of $198988. The stock is valued at a price-to-earnings (P/E) ratio of 0.04, price-to-book of 0.02, price-to-sales of 0.25. Over the past 52 weeks the stock has ranged between $0.43 and $372.00, and currently trades 99.7% below its 52-week high.

On profitability, NIVF generates a return on equity (ROE) of 37.04% — well above the market average, a sign of a high-quality business, return on capital employed of -42.31%, an operating margin of -220.00%, a net profit margin of 3.38%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides